The San Francisco 49ers were 3-4 after Week 7, a 44-23 loss to the Kansas City Chiefs. They haven't lost since.
What a week it was for the NFC in Week 17 of the NFL season and Tony Anderson is here to overreact to all the biggest storylines.The San Francisco 49ers were 3-4 after Week 7, a 44-23 loss to the Kansas City Chiefs.
Third-string QB Brock Purdy has been efficient for the 49ers, while RB Christian McCaffrey and the San Francisco defense have been nothing short of phenomenal. Lost to Jaguars, 31-3, to fall to 2-13-1. The Texans have to take a quarterback with their first pick in the NFL draft, right?Lost to Lions, 41-10, to fall to 3-13. Chicago has lost nine straight games. That won't cut it for the Bears, no matter how much promise Justin Fields has shown.Lost to Falcons, 20-19, to fall to 4-12. Arizona hasn't won since Week 10 and faces a 49ers team in Week 18 that hasn't lost since Week 7.Lost to Chiefs, 27-24, to fall to 4-12.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NFL Power Rankings: Where All 32 Teams Stand After Sunday's Week 17 ActionHere’s what the NFL hierarchy looks like with the penultimate week of the regular season nearly complete.
Read more »
French Mediterranean spot coming to NoPa, Zaytoon ends 13-year S.F. run - San Francisco Business TimesIt will replace Zaytoon's last location, ending the restaurant's 13-year run in San Francisco.
Read more »
San Francisco close to breaking single wettest-day recordThe last single-day record was in 1994. And record-keeping goes back to 1849.
Read more »
S.F.'s first Georgian restaurant coming to North Beach - San Francisco Business TimesThe team behind the Bay Area's second Georgian spot is bringing San Francisco its first.
Read more »
S.F. grocery delivery giant Instacart trims valuation - San Francisco Business TimesInstacart cut its meaty valuation back in March. Here's how much it's just trimmed it again. bayarea technews
Read more »
Genentech wins FDA approval of bispecific blood cancer drug Lunsumio - San Francisco Business TimesAnother bispecific antibody — linking to two key players in the fight against cancer — could be approved by regulators as soon as this spring.
Read more »